Osteotech Inc. (NASDAQ:OSTE) announced Tuesday it hasentered into an agreement with Abtox Inc. of Chicago to obtainequipment and the exclusive worldwide license to use Abtox'svapor phase plasma technology for the sterilization ofmusculoskeletal tissue.
Osteotech (NADSAQ:OSTE) of Shrewsbury, N.J., will pay$600,000 over 24 months. The agreement is subject to thecompletion of testing and validation of the Abtox equipment,Osteotech said. The company will also pay a royalty on alltissue it processes using the technology.
(c) 1997 American Health Consultants. All rights reserved.